Evolus (EOLS) Capital Expenditures (2018 - 2026)
Evolus (EOLS) reported Capital Expenditures of $415000.0 for Q1 2026, up 30.09% on a YoY basis from $319000.0 in Q1 2025, and down 71.94% quarter-over-quarter from $1.5 million in Q4 2025.
Evolus (EOLS) Capital Expenditures (2018 - 2026) Analysis & Trends
Evolus has reported Capital Expenditures for 9 years, with the latest figure at $415000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 30.09% year-over-year to $415000.0; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (up 1022.86% YoY), and the FY2025 full-year result was $3.4 million, up 1265.48% from the prior year.
- Capital Expenditures for Q1 2026 stood at $415000.0, down from $1.5 million in the prior quarter.
- The five-year high for Capital Expenditures was $1.5 million in Q4 2025, with the low at -$782000.0 in Q4 2024.
- Historically, Capital Expenditures has averaged $347176.5 across 5 years, with a median of $313000.0 in 2024.
- Annual changes were most pronounced in 2022 — Capital Expenditures soared 7600.0% — and 2024, when it plunged 474.16%.
- Evolus' Capital Expenditures stood at $569000.0 in 2022, then plunged by 63.27% to $209000.0 in 2023, then sank by 474.16% to -$782000.0 in 2024, then surged by 289.13% to $1.5 million in 2025, then tumbled by 71.94% to $415000.0 in 2026.
- The last three Capital Expenditures figures came in at $415000.0 (Q1 2026), $1.5 million (Q4 2025), and $955000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn | 415,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 415,000.00 |
| Mar 31, 2026 | 415,000.00 |
| Dec 31, 2025 | 1.48 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 955,000.00 |
| Sep 30, 2025 | 955,000.00 |
| Jun 30, 2025 | 688,000.00 |
| Jun 30, 2025 | 688,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Dec 31, 2024 | -782,000.00 |
| Dec 31, 2024 | -782,000.00 |
| Sep 30, 2024 | 313,000.00 |
| Sep 30, 2024 | 313,000.00 |
| Jun 30, 2024 | 465,000.00 |
| Jun 30, 2024 | 465,000.00 |
| Mar 31, 2024 | 256,000.00 |
| Mar 31, 2024 | 256,000.00 |
| Dec 31, 2023 | 209,000.00 |
| Dec 31, 2023 | 209,000.00 |